Markers of neurodegeneration and oxidative stress and speed of progression in multiple sclerosis

Markers of neurodegeneration and oxidative stress and speed of progression in multiple sclerosis - Markers of neurodegeneration in MS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30350

Enrollment

180

Registered

2006-12-28

Start date

2006-10-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age of eightteen years or older - written informed consent - MS-patients: a diagnosis of multiple sclerosis, according to the McDonald-criteria.

Exclusion criteria

Exclusion criteria: - contraindication for taking a blood sample

Design outcomes

Primary

Measure	Time frame
- The correlation of the measured biomarkers and skin autofluorescence with the porgression of disability (as measured with the EDSS and MSSS scales) over a period of five and ten years	—

Secondary

Measure	Time frame
- The correlation of the measured variables with fatigue (measured with the FSS scale) - The difference in the measured variables between MS-patients and healthy control persons	—

Countries

Netherlands

Outcome results